Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group
- 1 January 2019
- journal article
- review article
- Published by Elsevier BV in Lung Cancer
- Vol. 127, 69-75
- https://doi.org/10.1016/j.lungcan.2018.11.032
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesotheliomaHuman Pathology, 2015
- Prognostic Significance of Ki67 Expression in Malignant Peritoneal MesotheliomaAmerican Journal of Clinical Oncology, 2015
- MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the LungClinical Cancer Research, 2015
- Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patientsPathology, 2014
- Prognostic factors influencing survival in 35 patients with malignant peritoneal mesotheliomaNeoplasma, 2014
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest GroupArchives Of Pathology & Laboratory Medicine, 2013
- Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH GroupJournal of Thoracic Oncology, 2012
- A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesotheliomaLaboratory Investigation, 2012
- Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest GroupJournal of Thoracic Oncology, 2011
- Regulation of cardiovascular development and integrity by the heart of glass–cerebral cavernous malformation protein pathwayNature Medicine, 2009